Watchlist Price Alert

Barinthus Biotherapeutics (BRNS)

NASDAQ: BRNS · Real-Time Price · USD

0.93

-0.16 (-14.68%)

At close: May 02, 2025, 3:59 PM

0.95

2.27%

After-hours: May 02, 2025, 04:05 PM EDT

Barinthus Biotherapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Cash & Equivalents	110.66M	106.1M	117.77M	129.97M	142.09M	160.31M	173.03M	191.33M	194.38M	200.1M	192.33M	200.6M	214.05M	233.87M	243.62M	155.94M	43.27M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	-11.18M	n/a	n/a	n/a	-8.93M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	10.69M	926K	886K	885K	882K	1.05M	1.01M	1.03M	976K	847K	902K	788K	804K	719K	n/a	n/a	n/a
Receivables	7.14M	28.09M	13.48M	6.39M	7.94M	5.89M	10.3M	8.79M	12.21M	10.48M	33.29M	28.38M	11.72M	5.99M	5.6M	4M	4.61M
Inventory	n/a	n/a	n/a	1.00	1.00	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	2.08M	464K	626K	1.68M	14.81M	355K	1.45M	549K	563K	130K	730K	1.81M	995K	482K	6K	n/a	29K
Total Current Assets	125.74M	134.65M	131.88M	143.13M	156.91M	171.06M	184.78M	200.66M	213.04M	218.62M	226.29M	230.78M	226.76M	245.98M	256.73M	163.37M	47.9M
Property-Plant & Equipment	11.76M	18.16M	18.25M	18.94M	19.4M	19.74M	21.45M	20.43M	15.71M	14.32M	15.38M	11.28M	9.09M	9.81M	3.08M	3.1M	2.77M
Goodwill & Intangibles	21.95M	34.95M	35.74M	36.53M	37.32M	38.11M	38.9M	39.69M	40.48M	41.69M	42.48M	43.27M	44.06M	n/a	n/a	n/a	n/a
Total Long-Term Assets	44.4M	54.03M	54.87M	56.35M	57.6M	58.91M	61.35M	61.15M	57.16M	56.86M	58.77M	55.34M	53.95M	10.59M	3.11M	3.13M	2.77M
Total Assets	160.33M	188.69M	186.75M	199.48M	214.51M	229.97M	246.13M	261.82M	270.2M	275.48M	285.06M	286.12M	280.71M	256.57M	259.84M	166.49M	50.67M
Account Payables	2.47M	3.08M	2.56M	1.16M	1.6M	5.14M	2.43M	4.33M	3.75M	2.41M	4.47M	4.66M	2.42M	1.34M	4.68M	4.83M	4.67M
Deferred Revenue	1.74M	2.04M	839K	1.43M	n/a	n/a	-0.00	0.00	0.00	111K	136K	162K	182K	196K	217K	346K	245K
Short-Term Debt	n/a	n/a	1.92M	n/a	1.78M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	159K	n/a	n/a	n/a	n/a
Other Current Liabilities	1.77M	7.97M	6.14M	6.52M	4.23M	9.19M	6.97M	558K	1.93M	8.85M	3.69M	533K	1.42M	2.24M	740K	1.21M	753K
Total Current Liabilities	15.66M	15.07M	15.59M	12.84M	12.6M	18.57M	12.11M	11.99M	12.24M	14.03M	12.17M	16.48M	11.16M	6.37M	8.54M	8.65M	7.64M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	44.7M
Other Long-Term Liabilities	4.01M	3.02M	3.23M	3.2M	3.15M	3.08M	3.42M	3.02M	2.68M	3.55M	3.5M	2.88M	2.37M	n/a	n/a	209.24M	33.77M
Total Long-Term Liabilities	14.54M	14.16M	14.37M	14.63M	14.91M	15.8M	16.55M	16.26M	14.76M	17.3M	18.12M	16.5M	17M	7.73M	1.38M	210.67M	79.94M
Total Liabilities	30.19M	29.23M	29.96M	27.47M	27.51M	34.37M	28.67M	28.25M	27M	31.33M	30.29M	32.99M	28.15M	14.1M	9.93M	219.32M	87.58M
Total Debt	12.01M	12.67M	12.57M	12.81M	12.98M	12.7M	12.18M	10.65M	8.77M	8.26M	8.61M	6.74M	7.22M	8.16M	1.59M	1.63M	46.36M
Common Stock	1K	1K	87K	87K	87K	1K	1K	1K	1K	1K	1K	1K	1K	1K	1K	86K	n/a
Retained Earnings	-237.66M	-217.12M	-209.01M	-192.08M	-176.59M	-159.3M	-145.22M	-121.42M	-103.24M	-82.05M	-90.3M	-105.99M	-108.58M	-93.47M	-88.92M	-72.99M	-57.72M
Comprehensive Income	-25.87M	-15.55M	-24.73M	-24.89M	-23.32M	-31.1M	-23.29M	-28.89M	-33.46M	-51.14M	-31.23M	-14.46M	-8.49M	-9.04M	-2.58M	-2.66M	-1.24M
Shareholders Equity	130.03M	159.29M	156.62M	171.83M	186.78M	195.4M	217.21M	233.3M	242.9M	243.84M	254.4M	252.74M	252.13M	241.98M	249.39M	-53.11M	-37.3M
Total Investments	n/a	n/a	n/a	n/a	-11.18M	n/a	n/a	n/a	-8.93M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a